Company intelligence / Profile preview

Natac

Hervás, Extremadura, Spaininfo.natacs.aero ↗

Ownership: Private
Development stage: Other

Overview

Natac has demonstrated the ability to bring botanical and omega-3 based ingredients to commercial scale with scientific and clinical support for bioactivity, in both human and animal health settings, and has GMP-certified manufacturing for APIs. Product-specific clinical results are not publicly detailed for pharmaceuticals, but many of their nutraceutical ingredients are supported by preclinical and clinical research[5][4][2].

Therapeutic areas: Metabolic DisordersNeurologyOther
Modalities: Small moleculeProteinOilBotanical extract
Industry: Food & Nutrition

Partnerships

IFFE Biotech [8]

Beyond the preview

Go deeper on Natac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natac.

Explore the full profile